The overall goal of this project is to understand how association among viral and cellular transactivators can alter patterns of transcriptional regulation. We study how the activities of the cellular POU-homeo-domain transcription factor Oct-1 are modified by association with viral and cellular co-regulators, principally the herpes simplex virus (HSV) transactivator VP16. VP16 (also referred to as Vmw65 and aTIF) is a virion protein that upon HSV infection is released into the cell and activates transcription of the HSV immediate early (IE) genes by directing formation of a multiprotein-DNA complex---the VP16-induced complex----with Oct- 1 and a second cellular factor called HCF. Upon entry into the cell, VP16 first associated with HCF (also referred to as C1, VCAF, and CFF) independently of DNA, and then associates with the DNA- binding domain of Oct-1, a POU domain, on the cis-regulatory target of VP16 activation, the IE promoter-specific TAATGARAT (where R = purine) motif. Oct-1 also associates with a cell-specific co- regulator call OCA-B (also referred to as OBF-1 and Bob1) and an snRNA-specific basal regulatory complex call SNAPc or PTF. In this project, we will study how co-regulators associate with the Oct-1 POU domain and modify the activity of Oct-1, placing particular emphasis on the structure and function of the VP16 -induced complex. We will (I) analyze the three-dimensional structure of the VP16-induced complex; (ii) characterize Oct-1 POU- domain interactions with DNA and the viral co-regulator VP16; (iii) determine the mechanisms by which VP16 directs formation of the VP16-induced complex; (iv) elucidate the role of HCF in stabilization of the VP16-induced complex; and (v) characterize Oct- 1 POU-domain interactions with the cellular co-regulator OCA-B and the basal regulatory complex SNAPc.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA013106-27
Application #
6268642
Study Section
Project Start
1998-01-19
Project End
1998-12-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
27
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Cold Spring Harbor Laboratory
Department
Type
DUNS #
065968786
City
Cold Spring Harbor
State
NY
Country
United States
Zip Code
11724
On, Kin Fan; Jaremko, Matt; Stillman, Bruce et al. (2018) A structural view of the initiators for chromosome replication. Curr Opin Struct Biol 53:131-139
Knott, Simon R V; Wagenblast, Elvin; Khan, Showkhin et al. (2018) Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 554:378-381
Shamay, Yosi; Shah, Janki; I??k, Mehtap et al. (2018) Quantitative self-assembly prediction yields targeted nanomedicines. Nat Mater 17:361-368
Tramentozzi, Elisa; Ferraro, Paola; Hossain, Manzar et al. (2018) The dNTP triphosphohydrolase activity of SAMHD1 persists during S-phase when the enzyme is phosphorylated at T592. Cell Cycle 17:1102-1114
Arun, Gayatri; Diermeier, Sarah D; Spector, David L (2018) Therapeutic Targeting of Long Non-Coding RNAs in Cancer. Trends Mol Med 24:257-277
Tarumoto, Yusuke; Lu, Bin; Somerville, Tim D D et al. (2018) LKB1, Salt-Inducible Kinases, and MEF2C Are Linked Dependencies in Acute Myeloid Leukemia. Mol Cell 69:1017-1027.e6
Xu, Yali; Milazzo, Joseph P; Somerville, Tim D D et al. (2018) A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia. Cancer Cell 33:13-28.e8
Huang, Yu-Han; Klingbeil, Olaf; He, Xue-Yan et al. (2018) POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer. Genes Dev 32:915-928
Livshits, Geulah; Alonso-Curbelo, Direna; Morris 4th, John P et al. (2018) Arid1a restrains Kras-dependent changes in acinar cell identity. Elife 7:
Tiriac, Hervé; Belleau, Pascal; Engle, Dannielle D et al. (2018) Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov 8:1112-1129

Showing the most recent 10 out of 610 publications